Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15466703 | 0.96 | ALDH1A1 (0.32) | ALDH1A1GAATDP1 | |
| SCHEMBL7535152 | 0.87 | KDM4E (0.32) | ALDH1A1GAATDP1 | |
| SCHEMBL409464 | 0.83 | HSD11B1 (0.32) | ALDH1A1GAATDP1 | |
| SCHEMBL15467476 | 0.82 | — | — | |
| SCHEMBL249375 | 0.81 | HSD11B1 (0.35) | ALDH1A1GAATDP1 | |
| SCHEMBL250942 | 0.81 | HSD11B1 (0.35) | ALDH1A1GAATDP1 | |
| SCHEMBL28367030 | 0.76 | EPAS1 (0.30) | — | |
| SCHEMBL11983382 | 0.76 | ALDH1A1 (0.30) | ALDH1A1GAATDP1 | |
| SCHEMBL15467512 | 0.75 | ALDH1A1 (0.35) | ALDH1A1GAATDP1 | |
| SCHEMBL15467757 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10227433-B2 | Cycloalkylnorbornene monomers, polymers derived therefrom and their use in pervaporation | PROMERUS, LLC (US) | 2019-03-12 | — | — | US | disclosed |
| US-20160369026-A1 | CYCLOALKYLNORBORNENE MONOMERS, POLYMERS DERIVED THEREFROM AND THEIR USE IN PERVAPORATION | PROMERUS, LLC (US) | 2016-12-22 | — | — | US | disclosed |
| US-9468890-B2 | Cycloalkylnorbornene monomers, polymers derived therefrom and their use in pervaporation | PROMERUS, LLC (US) | 2016-10-18 | — | — | US | disclosed |
| EP-2870129-B1 | CYCLOALKYLNORBORNENE MONOMERS, POLYMERS DERIVED THEREFROM AND THEIR USE IN PERVAPORATION | SUMITOMO BAKELITE CO (JP) | 2016-04-06 | — | — | EP | disclosed |
| US-20140042090-A1 | CYCLOALKYLNORBORNENE MONOMERS, POLYMERS DERIVED THEREFROM AND THEIR USE IN PERVAPORATION | PROMERUS, LLC (US) | 2014-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160369026-A1 | CYCLOALKYLNORBORNENE MONOMERS, POLYMERS DERIVED THEREFROM AND THEIR USE IN PERVAPORATION | NOTUM, AGPS, WEE1 | ALDH1A1 3394/4885GAA 2851/4885TDP1 2684/4885 |
| US-10227433-B2 | Cycloalkylnorbornene monomers, polymers derived therefrom and their use in pervaporation | NOTUM, AGPS, WEE1 | ALDH1A1 3394/4885GAA 2851/4885TDP1 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.